CHARLIE JACQUES: Open Payments
NPI 1336162890 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 50 payments from 18 companies in 2025. Trend: 2023 $725 · 2024 $1,019 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $187 |
| Abbott Laboratories | 5 | $90 |
| Sequel Med Tech, LLC | 3 | $82 |
| BETA BIONICS, INC. | 5 | $75 |
| Amgen Inc. | 3 | $58 |
| Chiesi USA, Inc. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Tandem Diabetes Care, Inc. | 2 | $51 |
| Alexion Pharmaceuticals, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
Products named: FREESTYLE LIBRE 3, Rybelsus, TWIIST, iLet Bionic Pancreas, JARDIANCE, MYCAPSSA, LEQVIO, Ozempic.
Industry payments across UT — which companies pay providers there.
